No COVID-19 Herd Resistance Likely Till November

No COVID-19 Herd Resistance Likely Till November

Korea will not achieve herd immunity against coronavirus until November this year, health authorities here warned Tuesday.

The Korea Illness Control and Avoidance Firm stated coronavirus vaccinations will begin next month, but people between 19-49 who make up the bulk of the workforce will not get vaccinated up until the third quarter, when all high-risk or priority groups have actually been inoculated.

The government wishes to administer the vaccines as quick as possible to accomplish herd resistance or a threshold of 70 percent of the population being immune. The KDCA stated it is will cover part of the cost from government coffers or health insurance reserves.

The government has now signed agreements for the purchase of Pfizer, Moderna and AstraZeneca vaccines, where immunity takes place 2 to 3 weeks after the first dose. Priority will be offered to people with persistent diseases, the elderly and medical experts.

Individuals brave heavy snow to get tested for coronavirus at a makeshift facility in Seoul on Tuesday./ Yonhap

In a meeting on Tuesday, Prime Minister Chung Sye-kyun stated the federal government has actually worked hard to buy extra vaccines so individuals can be immunized safely and in a prompt manner. He added Korea is set to sign a handle U.S. drugmaker Novavax to acquire vaccines for another 10 million individuals by the 2nd quarter of this year.

Once the Novavax vaccines, whose phase 3 scientific trials began in late December in the U.S., arrive, Korea will have sufficient vaccines for 66 million people, way more than the population of 52 million.

President Moon Jae-in on Monday guaranteed all Koreans will be vaccinated totally free. Formerly, the federal government had prepared to supply only top priority recipients with complimentary vaccinations. Japan and China also chose to provide their individuals with totally free vaccinations to accomplish herd resistance.

One downside of complimentary vaccinations is that individuals will not be able to choose their brand name. “It will be tough to provide individuals an option since the federal government has to think about the timing of arrival and concern of recipients,” KDCA chief Jeong Eun-kyeong stated earlier today.

AstraZeneca’s vaccine, which will appear in February, is priced at US$ 3 to $4 per dosage. Others are more pricey– Moderna $25, Janssen $14 to $25 and Pfizer $20

Meanwhile, Korea reported 562 brand-new coronavirus cases as of Wednesday morning, bringing the overall tally to 70,212

  • Copyright © Chosunilbo &

Learn More

Search Medical Assistant Programs

Get information on Medical Assistant programs by entering your zip code and request enrollment information.

Sponsored Ad